GENE ONLINE|News &
Opinion
Blog

2025-05-02|

HHS Allocates $500 Million for Universal Vaccine Development Targeting Pandemic-Potential Viruses

by Mark Chiang
Share To

NEWSFLASH

The U.S. Department of Health and Human Services (HHS) recently announced a $500 million initiative aimed at expediting the creation of universal vaccines. These vaccines will target viruses known to have the potential to cause pandemics. The HHS is allocating this significant funding to stimulate research and development in the field of universal vaccine technology. The ultimate goal is to create vaccines that offer broad protection against multiple variants of a virus, or even entire families of viruses, thereby mitigating the threat of future pandemics. This investment underscores the government’s commitment to proactive pandemic preparedness and bolstering public health infrastructure.

Newsflash | Powered by GeneOnline AI
Date: May 2, 2025

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Related Post
CRISPR Makes History with First One-of-a-Kind Gene Therapy for Infant
2025-05-16
LATEST
CRISPR Makes History with First One-of-a-Kind Gene Therapy for Infant
2025-05-16
VintaBio Showcases High-Yield VintaProcess Platform for Gene Therapy Vector Production at ASGCT 2025
2025-05-15
Neurodegenerative and Metabolic Disease Challenges and Solutions at ASGCT 2025
2025-05-15
Boehringer Ingelheim and Tempus AI Partner in Multi-Year Collaboration to Enhance Oncology Drug Development
2025-05-15
Study: Aligning U.S. Drug Prices with Europe Could Reduce American Life Expectancy by Six Months
2025-05-15
Tribal Leaders Warn Senators: Federal Health Funding Cuts Threaten Native American Health.
2025-05-14
Health Secretary Kennedy Retracts Parts of Agency Reorganization Plan During Combative Congressional Hearing
2025-05-14
EVENT
2025-05-13
ASGCT 28th Annual Meeting 2025
New Orleans, U.S.A.
2025-05-30
ASCO Annual Meeting 2025
Chicago, U.S.A
2025-06-11
ISSCR 2025 Annual Meeting
Hong Kong
2025-06-16
US BIO International Convention
Boston, U.S.A.
Scroll to Top